Sunshine Biopharma (SBFM) EPS (Basic) (2017 - 2026)
Sunshine Biopharma's (SBFM) quarterly EPS (Basic) came in at -$2.54 in Q1 2026, up 41.9% YoY from -$1.79 in Q1 2025, and up 50.77% on a QoQ basis from -$5.15 in Q4 2025.
Sunshine Biopharma (SBFM) EPS (Basic) (2017 - 2026) Analysis & Trends
Sunshine Biopharma (SBFM) has 9 years of EPS (Basic) data on file, last reported at -$2.54 in Q1 2026.
- Quarterly EPS (Basic) rose 41.9% year-over-year to -$2.54 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$12.31 (up 47.29% YoY) and the FY2025 annual result came in at -$14.37, up 80.35% from the prior year.
- EPS (Basic) grew to -$2.54 in Q1 2026, from -$5.15 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $0.65 in Q3 2025 to a low of -$30978.0 in Q4 2022.
- A 5-year average of -$2497.6 and a median of -$400.31 in 2024 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2022 — EPS (Basic) sank 708.31% — and 2025, when it soared 106.87%.
- Tracing SBFM's EPS (Basic) over 5 years: stood at -$30978.0 in 2022, then surged by 96.79% to -$995.87 in 2023, then jumped by 96.91% to -$30.75 in 2024, then surged by 83.25% to -$5.15 in 2025, then soared by 50.77% to -$2.54 in 2026.
- The last three EPS (Basic) figures came in at -$2.54 (Q1 2026), -$5.15 (Q4 2025), and $0.65 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | -0.49 |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 2.07 |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 0.45 |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 7.82 |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | -0.10 |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 1.43 |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 0.11 |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Sunshine Biopharma | 1.54 Mn | -12.21 Mn | 2.43 Mn | -1.15 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.15 |
| Mar 31, 2026 | -2.54 |
| Dec 31, 2025 | -5.15 |
| Sep 30, 2025 | 0.65 |
| Jun 30, 2025 | -6.56 |
| Mar 31, 2025 | -4.36 |
| Dec 31, 2024 | -30.75 |
| Sep 30, 2024 | -9.45 |
| Jun 30, 2024 | -357.55 |
| Mar 31, 2024 | -400.31 |
| Dec 31, 2023 | -995.87 |
| Sep 30, 2023 | -506.99 |
| Jun 30, 2023 | -711.44 |
| Mar 31, 2023 | -1,544.85 |
| Dec 31, 2022 | -30,978.02 |
| Sep 30, 2022 | -1,543.45 |
| Jun 30, 2022 | -680.39 |
| Mar 31, 2022 | -4,682.70 |
| Dec 31, 2021 | 5,092.49 |
| Sep 30, 2021 | -31,806.17 |